Skip to main content
Journal cover image

Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy.

Publication ,  Journal Article
Chappidi, MR; Kates, M; Patel, HD; Tosoian, JJ; Kaye, DR; Sopko, NA; Lascano, D; Liu, J-J; McKiernan, J; Bivalacqua, TJ
Published in: Urol Oncol
June 2016

OBJECTIVE: To investigate the modified frailty index (mFI) as a preoperative predictor of postoperative complications following radical cystectomy (RC) in patients with bladder cancer. MATERIALS AND METHODS: Patients undergoing RC were identified from the National Surgical Quality Improvement Program participant use files (2011-2013). The mFI was defined in prior studies with 11 variables based on mapping the Canadian Study of Health and Aging Frailty Index to the National Surgical Quality Improvement Program comorbidities and activities of daily livings. The mFI groups were determined by the number of risk factors per patient (0, 1, 2, and≥3). Univariable and multivariable regression were performed to determine predictors of Clavien 4 and 5 complications, and a sensitivity analysis was performed to determine the mFI value that would be a significant predictor of Clavien 4 and 5 complications. RESULTS: Of the 2,679 cystectomy patients identified, 843 (31%) of patients had an mFI of 0, 1176 (44%) had an mFI of 1, 555 (21%) had an mFI of 2, and 105 (4%) had an mFI≥3. Overall, 1585 (59%) of patients experienced a Clavien complication. When stratified at a cutoff of mFI≥2, the overall complication rate was not different (61.7% vs. 58.3%, P = 0.1), but the mFI2 or greater group had a significantly higher rate of Clavien grade 4 or 5 complications (14.6% vs. 8.3%, P<0.001) and overall mortality rate (3.5% vs. 1.8%, P = 0.01) in the 30-day postoperative period. The multivariate logistic regression model showed independent predictors of Clavien grade 4 or 5 complications were age>80 years (odds ratio [OR] = 1.58 [1.11-2.27]), mFI2 (OR = 1.84 [1.28-2.64]), and mFI3 (OR = 2.58 [1.47-4.55]). CONCLUSIONS: Among patients undergoing RC, the mFI can identify those patients at greatest risk for severe complications and mortality. Given that bladder cancer is increasing in prevalence particularly among the elderly, preoperative risk stratification is crucial to inform decision-making about surgical candidacy.

Duke Scholars

Published In

Urol Oncol

DOI

EISSN

1873-2496

Publication Date

June 2016

Volume

34

Issue

6

Start / End Page

256.e1 / 256.e6

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Urinary Bladder Neoplasms
  • Risk Assessment
  • Retrospective Studies
  • Quality Improvement
  • Postoperative Complications
  • Middle Aged
  • Male
  • Humans
  • Frailty
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chappidi, M. R., Kates, M., Patel, H. D., Tosoian, J. J., Kaye, D. R., Sopko, N. A., … Bivalacqua, T. J. (2016). Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy. Urol Oncol, 34(6), 256.e1-256.e6. https://doi.org/10.1016/j.urolonc.2015.12.010
Chappidi, Meera R., Max Kates, Hiten D. Patel, Jeffrey J. Tosoian, Deborah R. Kaye, Nikolai A. Sopko, Danny Lascano, Jen-Jane Liu, James McKiernan, and Trinity J. Bivalacqua. “Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy.Urol Oncol 34, no. 6 (June 2016): 256.e1-256.e6. https://doi.org/10.1016/j.urolonc.2015.12.010.
Chappidi MR, Kates M, Patel HD, Tosoian JJ, Kaye DR, Sopko NA, et al. Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy. Urol Oncol. 2016 Jun;34(6):256.e1-256.e6.
Chappidi, Meera R., et al. “Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy.Urol Oncol, vol. 34, no. 6, June 2016, pp. 256.e1-256.e6. Pubmed, doi:10.1016/j.urolonc.2015.12.010.
Chappidi MR, Kates M, Patel HD, Tosoian JJ, Kaye DR, Sopko NA, Lascano D, Liu J-J, McKiernan J, Bivalacqua TJ. Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy. Urol Oncol. 2016 Jun;34(6):256.e1-256.e6.
Journal cover image

Published In

Urol Oncol

DOI

EISSN

1873-2496

Publication Date

June 2016

Volume

34

Issue

6

Start / End Page

256.e1 / 256.e6

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Urinary Bladder Neoplasms
  • Risk Assessment
  • Retrospective Studies
  • Quality Improvement
  • Postoperative Complications
  • Middle Aged
  • Male
  • Humans
  • Frailty